Anticancer agent reduces complications after stem-cell transplant Oncology Nurse Advisor Anticancer agent reduces complications after stem-cell transplant. Vorinostat, a drug already approved by the FDA for the treatment of cutaneous T-cell lymphoma, has been found to reduce the risk of graft-versus-host disease (GVHD) in persons ... |
